NOVARTIND — Novartis India Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹33.71bn
- IN₹27.06bn
- IN₹3.54bn
Annual cashflow statement for Novartis India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -38.2 | 1,154 | 1,228 | 1,304 | 1,297 |
| Depreciation | |||||
| Non-Cash Items | -153 | -550 | -594 | -410 | -357 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 481 | -217 | 473 | -171 | -492 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 387 | 448 | 1,134 | 746 | 467 |
| Capital Expenditures | -5 | -3.1 | — | — | -3.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 875 | -1,529 | 331 | -33.1 | 180 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 870 | -1,533 | 331 | -33.1 | 176 |
| Financing Cash Flow Items | -0.4 | -0.5 | -0.1 | -0.1 | 0 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -356 | -305 | -1,210 | -642 | -639 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 901 | -1,389 | 255 | 71.1 | 4.3 |